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Abstract 
Huntington’s disease (HD) is a progressive, fatal neurodegenerative disease caused by an 
inherited CAG expansion on the Huntingtin (HTT) gene resulting in cognitive, affective, and 
motor related symptoms.  Although clinical diagnosis depends on the presence of Huntington’s 
chorea, a movement disorder consisting of irregular movements, cognitive symptoms appear 10-
15 years prior during the pre-manifest stage of the disease and are more debilitating to patients.  
One of the most important advances in HD research has been the generation of mouse models 
that recapitulate the features of human HD, allowing researchers to identify the pathogenic 
mechanisms associated with the disease and test the potential therapeutic treatments.  
Unfortunately, many treatments that have been successful in mouse models have failed to 
translate to humans when tested in pre-clinical trials.  This is partly because experimenters have 
largely focused on improving late-stage features of HD such as cell death and motor dysfunction, 
and utilized transgenic mouse that are severely impaired but poorly reproduce the pathogenic 
processes that underlie the disease.  In contrast, knock-in (KI) mouse models are genetically 
faithful to the human condition but remain underutilized in pre-clinical research due to their 
slower progression and subtle overt phenotype.  This thesis characterized the behavioral deficits 
associated with the HttQ111/+ KI mouse model of HD and discovered novel cognitive phenotypes 
that are characteristic of the pre-manifest stage of the disease.  At nine months of age, HttQ111/+ 
mice display improved procedural memory on the two-cue MWM, hypoactivity, reduced 
velocity, and increased anxiety during open field exploration, and intact spatial LTM with a 
reduction in the total number of investigations toward both objects during an object location task.  
Together, these tasks provide a number of robust behavioral phenotypes for use in pre-clinical 
research conducted in the HttQ111/+ mouse model of HD in the future. 
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 Behavioral Characterization of a Knock-In Mouse Model of Huntington’s Disease 
 Huntington’s disease (HD) is a fatal neurological disorder characterized by cognitive 
decline, affective disturbances, and progressive motor dysfunction (Walker, 2007).  The most 
prominent symptom is chorea, an involuntary movement disorder consisting of brief, irregular 
movements (Papoutsi, Labuschagne, Tabrizi, & Stout, 2014).  HD is caused by a coding 
cytosine-adenine-guanine (CAG) expansion on the Huntingtin (HTT) gene, where repeat lengths 
above 41 results in full penetrance of the disease (The Huntington’s Disease Collaborative 
Research Group, 1993).  A relationship exists between the length of the CAG expansion and the 
presentation of symptoms such that individuals who express a longer mutation are prone to an 
earlier onset of the disease (Penney, Vonsattel, MacDonald, Gusella, & Myers, 1997).  
Prevalence of HD is conservatively estimated at 5-7 cases per 100,000 people (Walker, 2007).  
 During the late 19th century, George Huntington became the first to describe the nature of 
the disease that now bears his name (Huntington, 1872).  Upon receiving his medical degree 
from Columbia University, Huntington returned to Long Island, New York to join the family 
practice where both his father and grandfather had served collectively for 78 years.  During that 
span, the Huntington family treated multiple generations of families afflicted by the lethal 
movement disorder known now as Huntington’s chorea (Dunlap, 1927).  Based on his 
longitudinal observations, Huntington (1872) published his first scientific paper titled “On 
Chorea” where he documented several central features of the disease including late 
manifestation, impairment of the mind, a tendency toward suicide, and the involuntary 
movement disorder that he deemed “hereditary chorea.”   
 Though Huntington was unaware of the pathophysiological mechanisms that cause the 
disease, he did accurately identify a number of key symptoms that define the illness.  Motor 
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abnormalities are the most recognizable feature, and clinical diagnosis of the disease depends on 
the presence of motor symptoms that are determined by a clinician to be “unequivocal signs of 
HD” as measured by the Unified Huntington’s Disease Rating Scale (UHDRS), the most 
commonly used clinical scale in HD (Loy & McCusker, 2013; Reilman, Leavitt, & Ross, 2014).  
However, the genetic mutation responsible for the disease also leads to affective disturbances 
including anxiety and depression, progressive psychiatric symptoms, reduced energy 
metabolism, and cognitive decline (Papoutsi et al., 2014; Walker, 2007).  Importantly, cognitive 
deficits are often described by patients as being more debilitating than motor abnormalities 
overall, and are highly predictive of both functional decline (Papoutsi, et al., 2014) and future 
nursing home placement (Paulsen, 2011).  Cognitive decline is detectable up to 20 years prior to 
the onset of motor dysfunction, but most often appears in the 10-year span leading up to clinical 
diagnosis of the disease (Papoutsi et al., 2014; Paulsen, 2011). 
Cognitive deficits in HD generally fall into two categories, those that occur prior to the 
manifestation of motor symptoms and those that occur after the disease has been clinically 
diagnosed (Giralt, Saavedra, Alberch, & Perez-Navarro, 2012).  Symptoms that arise during the 
prodromal phase of HD - or prior to the onset of motor dysfunction - generally include 
impairment in executive function (e.g. working memory, reasoning, planning, and execution), 
strategy shifting, procedural learning, motor learning (Giralt et al., 2012) and emotional 
recognition (Labuschagne et al., 2013; Novak et al., 2012).  During the manifest stage of HD - or 
following the onset of motor symptoms - deficits in recognition memory, spatial learning, and 
difficulties recalling episodic memories begin to emerge (Giralt et al., 2012).   
Alterations to the circuitry of cortico-striatal neuronal networks are responsible for the 
earliest cognitive deficits observed in HD.  Recognition that the corpus striatum (i.e. the caudate 
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nucleus, putamen, and globus pallidus) of HD patients is profoundly affected first gained 
acceptance during the early 20th century (Vonsattel, 1985).  In 1911, Alzheimer noted that 
neurodegenerative processes are apparent in the cerebral cortex of brains affected by HD, but 
considered them unlikely to be the anatomic basis of Huntington’s chorea since other diseases 
that cause excessive damage to the cortex fail to elicit the same pattern of deficits (Dunlap, 
1927).  To uncover the relationship between sub-cortical neurodegeneration and the pattern of 
deficits observed in HD, Dunlap performed an exhaustive study on the brains of 17 known HD 
patients and 12 probable cases for which the family history was unclear.  Although limited in the 
scientific tools available to him during his era, Dunlap correctly identified a number of the 
central neuropathological features of the disease which hold true to this day, such as profound 
neurodegeneration of the caudate and putamen, atrophied neuropil, reduced brain weight, 
progressive gliosis, and cerebellar preservation (Dunlap, 1927). 
Medium spiny neurons (MSNs) sensitive to gamma-aminobutyric acid (GABA) comprise 
90-95% of the neuronal population within the corpus striatum and are the most severely affected 
cellular subtype in HD.  To delineate the progression and features of neurodegeneration within 
the basal ganglia over time, Vonsattel et al. (1985) evaluated the half-brain specimens of 163 
clinically diagnosed HD patients and assigned a disease severity grade to each.  At the earliest 
stages, microscopic evaluations revealed cellular loss of MSNs within the medial portion of the 
caudate nucleus (with the tail showing more severe neurodegeneration than the head), as well as 
slight neurodegeneration within the dorsal putamen and moderate fibrillary astrocytosis.  
Throughout the progression of the disease, cellular loss and astrocytosis becomes more severe in 
both the striatum and surrounding subcortical structures, ultimately progressing in a dorsal to 
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ventral, medial to lateral, and caudo-rostral fashion within the basal ganglia (Lawrence, 
Sahakian, & Robbins, 1998; Papoutsi et al., 2014). 
Anatomically, the basal ganglia are composed of five interconnected nuclei: caudate, 
putamen, globus pallidus (GP) – distinguished by an internal (GPi) and external (GPe) segment, 
subthalamic nucleus (STN), and the substantia nigra (SN) – subdivided into the pars compacta 
(SNpc) and pars reticulata (SNpr) (Mink, 1996).  The striatum (i.e. the caudate and putamen) is 
the primary input into the basal ganglia, and receives excitatory glutamatergic afferents from 
nearly all areas of the cerebral cortex except for primary visual and auditory areas (Mink, 1996).  
Output from the striatum is composed mainly of inhibitory GABAergic MSNs and is 
anatomically sub-divided into a “direct” and “indirect” pathway which have opposing effects on 
thalamic output back to the cerebral cortex (Cohen & Frank, 2009; Mink, 1996).  Together, the 
two pathways act as a selection hub, facilitating desired actions and suppressing unwanted ones 
via a push/pull type gating mechanism comprised of multiple partially overlapping closed circuit 
feedback loops (Cohen & Frank, 2009; Mink, 1996).  For a schematic of basal ganglia anatomy, 
see Figure 1. 
Direct and indirect pathway MSNs are identifiable by the types of dopamine receptors 
and neuropeptides they express, as well as the subcortical nuclei they preferentially project to 
(Chen, Wang, Cepeda & Levine, 2013).  Direct pathway MSNs express primarily D1 receptors, 
substance P, dynophorin, and project monosynaptically onto the GPi and SNr (Chen et al., 2013; 
Cohen & Frank, 2009; Deng et al., 2004).  Activation of direct pathway MSNs provide focused 
inhibitory input onto the GPi and SNr, which subsequently disinhibit the thalamus and provide a 
net excitatory effect upon cortical activity via bottom up thalamocortical drive (Cohen & Frank, 
2009).  Indirect pathway MSNs, in contrast, express primarily D2 receptors, enkephalin, 
5 
 
adenosine A2A receptors (Deng et al., 2004), and send polysynaptic inhibitory efferents onto the 
GPe.  The GPe both tonically inhibits the GPi via direct focused projections (Cohen & Frank, 
2009), and projects inhibitory axon collaterals onto the STN, which in turn sends excitatory 
glutamatergic projections onto the GPi and SNr (Chen et al., 2013).  Thus, activation of indirect 
pathway neurons removes the tonic inhibition of GPe upon the GPi and STN, which further 
strengthens the inhibitory projections from the GPi and SNr upon the thalamus, providing a net 
inhibitory effect upon cortical activity overall (Cohen & Frank, 2009).   
Recent evidence suggests that a third, “hyper-direct”, pathway exists between the 
cerebral cortex and STN, in which direct excitatory projections from the neocortex synapse upon 
the STN and provide a global inhibitory response to the thalamus via the STN’s excitatory 
projections to the GPi and SNr (Cohen & Frank, 2009; Redgrave et al., 2010).  Global 
suppression via the hyper-direct pathway is observed early during response selection and is 
thought to be modulated by the degree of response conflict, such that actions with multiple 
competing responses elicit greater activation of the STN overall (Cohen & Frank, 2009).  
Computational neuroscientists hypothesize that the global suppression exerted by the STN and 
hyper-direct pathway afford the basal ganglia more time to both resolve the conflict between 
multiple competing responses and ensure that no action is selected prematurely (Frank, 2006).   
Dopaminergic projections originating in the caudal SN (i.e. SNpc) play an important role 
in signaling within the basal ganglia and partially modulate activation within the direct and 
indirect pathways (Papoutsi et. al, 2014).  Dopamine excites (i.e. activates) MSNs containing the 
D1 receptor subtype, preferentially expressed within the direct pathway, while inhibiting MSNs 
that possess the D2 receptor subtype, preferentially expressed within the indirect pathway.  In 
both cases, activation of dopaminergic projections within the basal ganglia serves to disinhibit 
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thalamic feedback to the cortex, creating a net excitation effect overall (Cohen & Frank, 2009).  
In this way, dopamine acts as a focusing mechanism - enhancing the “signal” being broadcast 
among highly active excitatory D1 cells while simultaneously decreasing the “noise” being 
emitted from less active inhibitory D2 cells during action selection (Cohen & Frank, 2009).   
In addition to facilitating action selection by differentially activating direct and indirect 
pathway MSNs, dopamine also plays a critical role in reinforcement learning and the acquisition 
of procedural tasks – processes that depend heavily upon the striatum (Cohen & Frank, 2009).  
Cortical regions associated with limbic (i.e. emotional), associative (i.e. cognitive) and 
sensorimotor function project largely segregated afferents to the striatum in a ventromedial to 
dorsolateral gradient (Redgrave et al., 2010).  In-vivo electrophysiological recordings taken from 
behaving animals show that during skill learning, early acquisition depends heavily upon 
activation of MSNs within the dorsomedial (associative) striatum while late stage consolidation 
relies primarily on the activation of MSNs in the dorsolateral (sensorimotor) striatum (Yin et al., 
2009).  Activation of MSNs during each phase of a skill-learning task is pathway specific, such 
that acquisition relies heavily upon the activation of D1 expressing striatonigral cells, while 
consolidation depends upon the activation of D2 expressing striatopallidal cells (Yin et al., 2009).  
Thus, as a skill becomes more automatic and well engrained into procedural memory, the activity 
of direct pathway MSNs gradually subside while the activity of indirect pathway MSNs slowly 
increase. 
 Implicit learning depends on the presence and timing of dopamine release within the 
basal ganglia, which then serves to modulate MSNs that have already been activated by cortico-
striatal glutamatergic input (Cohen & Frank, 2009).  Specifically, phasic bursts of dopamine (i.e. 
~100 ms latency; 100-200 ms duration) occur in response to unexpected rewards, and 
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dopaminergic firing drops below tonic baseline levels when a reward is expected but not 
received (Cohen & Frank, 2009; Redgrave, Gurney, & Reynolds, 2008).  Thus, when a specific 
action is successful or rewarding, phasic bursts of dopamine facilitate long-term potentiation 
(LTP) within the already activated cortico-baso-thalamic circuit.  In contrast, actions that fail to 
elicit reward or are deemed unsuccessful elicit tonic “dips” in dopamine levels which disinhibit 
indirect pathway MSNs (which are normally inhibited by dopamine via D2 receptors), inducing 
LTP along the indirect pathway circuitry responsible for suppressing that action in the future 
(Cohen & Frank, 2009).  In both cases, dopaminergic firing in the basal ganglia increases the 
likelihood of eliciting a successful response in response to the repeated presentation of a stimulus 
via Hebbian learning principles (Cohen & Frank, 2009). 
Although the underlying mechanisms are not well understood, early neurodegeneration in 
HD tends to spare MSN within the direct pathway expressing D1 receptors while MSN within the 
indirect pathway expressing D2 receptors do not survive (Deng et al., 2004; Papoutsi et al., 
2014).  This raises the possibility that neurodegeneration occurring along the indirect pathway of 
the basal ganglia can cause the cognitive deficits observed during the pre-manifest and early 
stages of HD (Chen et al., 2013, Papoutsi et al., 2014).  Dopamine receptor density is decreased 
in both pre-manifest and manifest HD (Chen et al., 2013), and neuroimaging studies suggest that 
a relationship between impaired dopamine receptor binding and the cognitive deficits observed 
in HD exists.  Lawrence et al. (1998) used positron emission tomography (PET) to correlate the 
binding affinity of dopamine to D1 and D2 receptor subtypes with multiple cognitive tasks known 
to be sensitive to cortico-striatal function in HD.  Results showed pre-manifest and manifest 
patients together were impaired on multiple cognitive tasks, and reduced binding affinity for D2 
receptor subtypes within the striatum was highly predictive of cognitive performance such that 
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patients who suffered the greatest impairments displayed the lowest levels of D2 receptor binding 
affinity within the striatum.  For a schematic of the gradient of pathology observed in the basal 
ganglia during the progression of HD, see Figure 2. 
 In addition to the effect that reduced dopamine receptor binding can have on cognitive 
performance, varying levels of dopamine within the striatum can also dramatically alter 
performance on basal ganglia dependent cognitive tasks.  In HD, extracellular striatal dopamine 
levels display bi-phasic, time dependent changes such that levels increase during the early stage 
of the disease, and decrease at the later stages of the disease (Chen et. al., 2013).  Patients of 
Parkinson’s disease, which is caused by striatonigral (i.e. direct pathway) dopamine depletion in 
the dorsolateral striatum during the early stages of the disease and mesocorticolimbic/ventral 
depletion in the later stages, provide a unique opportunity to examine this relationship (Cools et 
al., 2001).  Cools, Barker, Sahakian, and Robbins (2001) examined Parkinson’s disease patients 
medicated with L-DOPA to investigate how dopamine systems contribute to cognitive 
performance in the domain of learning and attentional flexibility.  After withdrawing L-DOPA 
medication, patients performed worse on a test of task-set switching known to depend on 
dorsolateral cortico-striatal circuits, while performance on a probabilistic reversal-learning task 
known to depend on orbitofrontal/ventral cortico-striatal circuitry improved.  When L-DOPA 
was re-administered, the opposite pattern emerged.  As the authors note, this is likely because 
administration of L-DOPA restored baseline levels of dopamine in the dorsolateral striatum (thus 
increasing performance on task-set switching), but “overdosed” the relatively intact 
orbitofrontal/ventral striatal circuitry (Cools et al., 2001).   
 Together, the evidence suggests that the timing of the cognitive declines observed during 
the early stages of HD may reflect the changes to the integrity of dopaminergic systems as well 
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as the topographical pattern of neurodegeneration observed as HD progresses (Papoutsi et al., 
2014).  Impaired signaling along the indirect pathway increases the tonic inhibition of the GPe 
upon the GPi and STN, which subsequently disinhibits thalamic feedback to the neocortex and 
allows competing responses to activate during action selection that would otherwise be 
suppressed (Papoutsi et al., 2014).  At the same time, direct pathway MSNs become over 
activated in the presence of increased levels of extracellular glutamate, leading to even greater 
disinhibition of the thalamus overall.  Dopamine’s role in modulating action selection and 
learning amplifies during the early stages of the disease and diminishes throughout disease 
progression (Chen et al., 2013).  Together, these deficits may manifest in perseveration, a classic 
symptom of HD that may be at the root of many of the cognitive deficits observed during the 
pre-manifest and early stages of the disease (Chen et. al., 2013; Giralt et al., 2012).  As such, 
increased dopamine levels may “overdose” regions of the basal ganglia that remain relatively 
spared, while compromised D2 receptor signaling in affected regions removes the ability to 
suppress competing response patterns.  While bi-phasic changes in dopamine levels have been 
linked to movement symptoms (i.e. increased dopamine levels predict the onset of chorea during 
early HD and decreased levels predict akinesia during late HD), further studies tightly linking 
neuropathology with function will be necessary to connect these changes to cognition (Chen et 
al., 2013; Papoutsi et al., 2014). 
As HD advances into the early and middle stages, a different cognitive profile begins to 
emerge.  Deficits associated with the pre-manifest stage of HD continue to worsen, and 
impairments in episodic memory, spatial memory, and recognition memory begin to arise (Giralt 
et al., 2012; Montoya et al., 2006).  While many attribute the deficits observed during manifest 
HD to the continued decline of cortico-striatal circuitry, this fails to incorporate the role of the 
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hippocampus and other related temporal lobe structures upon cognitive performance at this stage 
of the disease (Giralt et al., 2012).  It is now widely accepted that there are multiple, competing 
memory systems that interact depending on the type of cognitive task being performed (Giralt et 
al. 2012; Gold, 2004; Hartley & Burgess, 2005).  While implicit learning and non-declarative 
memory (i.e. procedural memory) depend largely upon activation of the striatum, spatial learning 
and declarative memory rely primarily upon the activation of the dorsal hippocampus (Hartley & 
Burgess, 2005; Poldrack et al., 2001).       
A remarkable feature of the human brain is that it is plastic, and can reorganize neuronal 
circuitry to compensate for injury.  In HD, functional imaging studies indicate that different brain 
regions such as the supplementary motor area, anterior cingulate, superior and inferior parietal 
lobe, premotor cortex, dorsolateral prefrontal cortex, and orbitofrontal cortex can play a 
compensatory role for striatal dysfunction depending upon the cognitive task being performed 
(Papoutsi et al., 2014).  In pre-manifest HD patients, decreases in metabolic activity in brain 
regions such as the caudate, putamen, thalamus, insula, posterior cingulate, prefrontal cortex and 
occipital cortex occur simultaneously with increases in metabolic activity in the cerebellum, 
pons, hippocampus, and orbitofrontal cortex (Tang et al., 2013).  Further, these shifts in 
metabolic activity become more pronounced over time, indicating a progressive compensatory 
network that is highly predictive of disease progression beyond volume loss alone (Tang et al., 
2013).  In manifest HD patients, Voermans et al. (2004) used fMRI to show that the 
hippocampus compensates for caudate dysfunction during a route-recognition task and patients 
maintain performance equal to that of healthy controls.  As Papoutsi et al. (2014) note, individual 
differences that exist between patients in the ability to enlist compensatory mechanisms may 
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explain a great deal of the variability that exists between patients regarding the onset and 
progression of cognitive symptoms in HD. 
A popular hypothesis links cognitive reserve (i.e. an individual’s resilience against and 
ability to compensate for neurodegeneration) to sustained cognitive ability as HD progresses 
(Bonner-Jackson et al., 2013; Papoutsi et al., 2014).  Papoutsi et al. (2014) posit that individuals 
possessing increased levels of cognitive reserve can process information more efficiently, and 
possess an increased ability to recruit new brain regions to compensate for a compromised neural 
network.  Environmental enrichment (which increases cognitive stimulation and activity levels) 
delays onset of motor symptoms and slows the rate of cortical atrophy in a transgenic mouse 
model of HD (Hockly et al. 2002).  Similarly, HD patients estimated to be closest to clinical 
onset possessing greater levels of cognitive reserve (as measured by a composite calculation of 
pre-morbid intellectual level, years of education, and occupational status) display slower rates of 
brain atrophy and cognitive decline compared to those with lower levels of cognitive reserve 
(Bonner-Jackson et al., 2013).  
Though the relationship between cortical and striatal atrophy is likely to be complex, the 
cognitive phenotype observed during manifest HD likely reflects a combination of continued 
striatal atrophy, the spreading of neurodegeneration among cortical pyramidal cells, and the 
subsequent failure of compensatory neural mechanisms that preserve cognitive function (Giralt 
et al., 2012; Rosas et al., 2008, Papoutsi et al. 2014).  Using magnetic resonance imaging (MRI), 
Rosas et al. (2003) showed that compared to controls, the most pronounced levels of atrophy in 
manifest HD patients occur in subcortical structures such as the caudate, putamen, globus 
pallidus, nucleus accumbens, and brainstem, although measureable cortical neurodegeneration is 
also observed in cerebral white matter, cerebral grey matter, and the hippocampus to a lesser 
12 
 
extent.  Similarly, cross-sectional analysis of brain imaging measures in late stage manifest HD 
patients revealed increased cortical thinning within areas of the cingulate, pre-central, pre-
frontal, occipital, parietal, and temporal cortices, accounting for as much as an 8.5% loss in 
volume compared to controls (Tabrizi et al., 2009).  Further, cortical thinning predicts reduced 
performance on multiple tests of the UHDRS cognitive scale (a widely used measure of 
cognitive function in HD), including tasks such as Stroop Color Word Association, Symbol Digit 
Modalities, and Verbal Fluency (Rosas et al., 2008).  The Verbal Fluency test is comprised of 
two variations, a phonetic version that depends on cortico-striatal circuitry, and a semantic 
version that depends on temporal lobe function (Baldo, Schwartz, Wilkens, & Dronkers, 2006).  
While manifest HD patients display deficiencies on both versions of the test, performance is 
impaired to greater extent on the phonetic version compared to the semantic version (Azmbujah, 
Haddad, Radanovic, Barbosa, & Mansur, 2007; Ho et al., 2002).   
Together, the collective findings suggest that degeneration in HD begins in the basal 
ganglia, manifesting in abnormal cognitive processes known to depend on cortico-striatal 
circuitry (Giralt et al., 2012; Papoutsi et al., 2014).  Throughout disease progression, atrophy 
within the basal ganglia becomes more severe and eventually progresses to the cortex, resulting 
in a failure of compensatory mechanisms and the appearance of deficits in new domains that 
depend less upon sub-cortical function and more upon the integrity of cortical structures (Giralt 
et al., 2012; Papoutsi et al., 2014).  In the final stages of the disease, widespread failure of both 
sub-cortical and cortical systems leads to sub-cortical dementia and alterations in both simple 
and complex functions.  Personality changes, decreased motivation, apathy, and depressive 
symptoms are commonly observed at this stage of the disease (Giralt et al., 2012). 
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Tabrizi et al. (2013) confirmed the overarching pattern of neurodegeneration seen in HD 
patients in a three-year longitudinal study of phenotypic progression known as TRACK-HD.  
Tabrizi and colleagues divided participants into one of four groups depending on the status of 
their diagnosis at baseline, using estimated years to onset and scores on total functional capacity 
(TFC) scale, which details level of function in the domains of workplace, finances, domestic 
chores, and activities of daily living.  Groups were defined as PreHD-A (>10.8 years to predicted 
onset), PreHD-B (<10.8 years to predicted onset), HD1 (manifest with a total functional capacity 
score of 11-13), and HD2 (manifest with a total functional capacity score of 7-10).  Results show 
that striatal volume is one of the most prominently recognizable clinical features among all 
subsets of patients, displaying a reduction in volume between 4.63% for PreHD-1 and 9.89% for 
HD2 over a three-year period (Tabrizi et al., 2013.)  In contrast, grey matter volume remained 
relatively conserved compared to controls in the PreHD-A group (0.1% reduction of baseline 
volume), whereas manifest HD patients displayed a marked loss of grey matter over time, with 
as much as a 1.38% loss of volume compared to baseline.  Interestingly, longitudinal changes in 
whole-brain atrophy, grey matter, white matter, caudate volumes, and impairments in emotional 
recognition were greater for pre-manifest patients who reached clinical diagnosis (i.e. were 
assigned a diagnostic confidence score of 4 on the UHDRS, signifying unequivocal presence of 
motor signs) during the study than those who did not.  Whereas no association between 
neuropsychiatric symptoms such as affect, irritability, and apathy upon TFC exists for pre-
manifest patients, these measures proved to be strong predictors of TFC decline for those with 
early-HD.  As Tabrizi et al. (2013) note, increasing grey matter atrophy, especially in 
extrastriatal regions, correlates strongly with clinical onset and decline in TFC, signifying that 
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grey matter loss is a key marker of both clinical onset and disease progression and displays 
predictive power above and beyond CAG repeat length and age. 
At the cellular level, the pathogenic hallmark of HD is cytoplasmic and intranuclear 
inclusions of aggregated mutant huntingtin protein (Walker, 2007).  It is unclear whether the 
formation of aggregates is ultimately neuroprotective or harmful; some studies have shown that 
cells which contain aggregates, as opposed to soluble fragments of the mutated protein, survive 
longer than those which do not (Arresate, Mitra, Schweitzer, Segal, & Finkbeiner, 2004).  
Research links the mutant huntingtin protein (mHTT) to a multitude of abnormal cellular 
processes, including impaired proteasomal function, impeded intracellular vesicle and receptor 
trafficking, altered transcriptional regulation, and dysfunctional signaling among neurotrophic 
pathways that are critical for cellular survival (Harjes & Wanker, 2003; Li & Li, 2004).   
Among the neurotrophic pathways that are altered in HD, many suggest that the brain 
derived neurotrophic factor (BDNF) signaling cascade plays a critical role in cellular 
degeneration and the manifestation of cognitive deficits (Li & Li, 2004; Milnerwood & 
Raymond, 2010).  BDNF is a neurotrophin that is critical to cellular survival, and is particularly 
important for enhancing synaptic transmission, promoting synaptic growth, and facilitating 
synaptic plasticity (Lu, Nagappan, Guan, Nathan, & Wren, 2013).  Reduced BDNF transmission 
remains a popular hypothesis because the huntingtin protein (HTT) modulates BDNF at the 
transcriptional level, and mHTT expression diminishes baseline levels of BDNF at many of the 
primary locations of pathophysiology associated with cognitive deficits in HD, including the 
striatum, neocortex, and hippocampus (Zuccato et al., 2001).   
Striatal MSNs are unable to produce BDNF on their own, and instead must rely on other 
areas of the brain for its synthesis and delivery.  Studies indicate that mHTT reduces both 
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anterograde and retrograde transport of vesicularized BDNF in vitro (Zala et al., 2008).  Further, 
mHTT reduces retrograde transport of TrkB receptors, the primary receptor for BDNF, through 
its interaction with dynein, a motor protein essential for transport of cellular cargo along 
microtubules in axons (Liot et al., 2013).  This raises the possibility that in HD, mHTT reduces 
BDNF supply to striatal neurons, and ultimately leads to neurodegeneration (Li & Li, 2004). 
Interestingly, genetically reducing the amount of mHTT expressed in cortical efferents improves 
electrophysiological and behavioral phenotypes in mice, supporting the hypothesis that mHTT 
alters cortical communication with their striatal targets by either impeding the delivery of critical 
trophic factors (e.g. BDNF) or disrupting the synchronicity of communication between cells at 
the network level (Estrada-Sanchez et al., 2015).  The BDNF hypothesis remains controversial, 
however, since other studies suggest that increased activation of the p75
 
neurotrophic receptor 
(p75NTR), a non-selective nerve growth factor receptor, may account for the reduced synaptic 
plasticity observed in HD (Plotkin, et al, 2014).  Whereas activation of TrkB receptors by BDNF 
promote neuronal survival, axonal outgrowth, and synaptic plasticity (i.e. LTP), activation of 
p75NTR facilitates cell death, inhibits axonal outgrowth, and is necessary for long-term depression 
(Chapleu & Pozzo-Miller, 2012).  Plotkin et al. (2014) failed to find altered striatal BDNF and 
TrkB mRNA in two mouse models of HD, suggesting impairment in BDNF plasticity must occur 
downstream of TrkB receptor binding.  When p75NTR receptors were knocked-down or 
inactivated, Plotkin et al. (2014) completely restored any synaptic LTP deficits previously 
observed.  It is interesting to note that p75NTR can be activated by a number of ligands, including 
BDNF itself, raising the possibility that in HD BDNF is both activating and inhibiting LTP 
through its interaction with TrkB receptors and p75NTR (Plotkin & Surmeier, 2014).  
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Importantly, synaptic pathophysiology occurs prior to cell death in both humans and 
animal models of the disease (Milnerwood et al., 2006; Orth et al., 2010).  Morphological 
changes are observed in the dendrites of MSNs in human HD patients, and a reduced number of 
dendritic spines are found in the MSNs in animal models of the disease (Smith, Brunden, & Lee, 
2005).  The finding that synaptic dysfunction in HD occurs prior to cell death is paramount, 
because it opens new avenues in regards to potential therapeutic interventions.  In that regard, it 
may be possible to reverse the effects of neurite loss and overall synaptic failure using drug 
therapy as long as the disease were diagnosed early enough in its progression (i.e. before cell 
death occurs).   
Mouse models are the most useful and practical tool to test potential therapies because 
they possess a homologous huntingtin gene (Hdh) that is roughly 91% identical to that of 
humans, and share many physiological and anatomical traits with humans (Barnes et al. 1994; 
Ehrnhoefer, Butland, Pouladi, & Hayden, 2009).  Though other animal models of HD exist (e.g. 
C. elegans, Drosophila, sheep, pigs, and monkeys), these models either fail to exhibit the 
behavioral complexity necessary to study complicated processes such as cognition, or incur 
many practical, financial, and ethical issues (Ehrnhoefer et al., 2009).  Thus, mouse models strike 
an important balance necessary to conduct research efficiently and practically.  Since a single 
genetic mutation is responsible for the pathogenesis observed in HD, several mouse models have 
been engineered to recapitulate the features of the disease seen in humans, although each differs 
in the manner that it is created and is distinguished by a unique set of strengths and weaknesses.  
At the present, three main types of genetically engineered mouse models exist: N-terminal 
transgenic, full-length transgenic and knock-in models (Menalled & Chesselet, 2002).  
Homozygous knock-out mice (i.e. completely inactivating the huntingtin gene) were created first 
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but animals created in this fashion fail to recapitulate the symptoms associated with human HD 
and die during embryonic development (Duyao et al., 1995).  Apart from identifying an 
important role for the huntingtin protein during embryogenesis (Duyao et al., 1995), this suggests 
that the pathology caused by the HD mutation is not due to loss of function alone (Duyao et al., 
1995, Menalled & Chesselet, 2002), and is more likely due to a combination gain of function and 
loss of function mechanisms together (Menalled & Chesellet, 2002). 
The first mouse model of HD to be created was an N-terminal fragment model, which 
was constructed by randomly inserting exon 1 of the mutated human huntingtin gene into the 
mouse genome via pronuclear injection.  Thus, N-terminal fragment mice express the mutated 
human gene in addition to two endogenous copies of the murine gene (Menalled, et al., 2014).  
This process is very disruptive to the mouse genome; inserting the affected human huntingtin 
gene has deleterious effects on mouse chromosomal DNA near the interaction site and can 
potentially introduce additional abnormalities on top of those caused by the mutant human 
huntingtin gene (Menalled et al., 2014).  The phenotype associated with N- terminal models is 
severe and rapid, a product of the fact that similar to humans, soluble N-terminal fragments of 
mHTT are more toxic than the full-length protein (Arresate et al., 2004).  The rapid disease 
progression associated with N-terminal transgenic model makes them among the cheapest to 
house and quickest to display pathological signs, making them the most popular model to use in 
pre-clinical research.  A review of pre-clinical trials conducted by Menalled and Brunner (2014) 
found that over half of the studies conducted utilized N-terminal fragment mice for their study.  
However, the rapid progression associated with the model also presents a disadvantage in that it 
is impossible to sequence the phenotypic progression of the disease, thus hampering the ability 
of researchers to measure deficits that characterize the pre-manifest stage of the disease. 
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 Full-length transgenic models of HD differ from N-terminal models in that a full-length 
copy of the mutated human gene is inserted into the mouse genome via a yeast or bacteria 
artificial chromosome (Menalled et al., 2014).  The reduced toxicity associated with the insertion 
of the full length gene results in a slower and more gradual expression of the disease phenotype 
in the mouse (Menalled et al., 2014), making it possible to clearly establish deficits which belong 
to the pre-manifest stage of the disease.  Issues with this model are still apparent, however, as 
full-length transgenic mice tend to gain weight compared to other models and healthy controls, a 
phenomenon that is uncharacteristic of human HD patients who instead display impaired energy 
metabolism and reduced body weight (Menalled et al., 2014).  Weight gain can confound results 
in experiments which the mice must utilize motor function to complete the task, ultimately 
affecting both tests designed to measure motor function (e.g. rotarod) and cognition (e.g. Morris 
water maze). 
 Unlike transgenic models, knock-in models (KI) are created by altering the length of the 
CAG tract in the homologous mouse huntingtin gene in embryonic stem cells (Menalled et al., 
2014), resulting in a number of advantages compared to other HD mice.  KI mice can be either 
homozygous or heterozygous for the Hdh gene; those expressing one mutant allele as well as one 
wild-type allele allow for proper gene dosage compared to the transgenic lines and are a more 
accurate depiction of the human condition (Menalled et al., 2014). KI mice are also a more 
precise representation of the human condition because the manipulation of mouse Hdh gene 
allows the endogenous murine promoter to control levels of gene expression (Menalled, 2005).  
Phenotypic expression KI mice most closely mimic that of humans, where initial abnormalities 
are very mild and closely resemble the pre-symptomatic stage of the disease.  For this reason, KI 
mice are among the highest in construct validity and one of the most useful tools to measure pre-
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symptomatic deficits such as cognition (Menalled, 2005).  At later stages, knock-in mice develop 
overt behavioral phenotypes including motor abnormalities (Menalled et al., 2014).  KI mice, 
and their relatively subtle phenotypes compared to other models do present a disadvantage in that 
it is difficult to measure phenotypic abnormalities reliably.  For this reason, Menalled and 
Brunner (2014) found in their review of pre-clinical trials that only 3% of the studies reviewed 
utilized knock-in models for their studies. 
 Many therapies have been successful in animal models of HD, only to fail when tested in 
humans (Menalled & Brunner, 2014).  Multiple explanations exist, ranging from the lack of 
robustness in pre-clinical studies to the misuse of statistical analysis methods (Menalled & 
Brunner, 2014).  Ioannidis (2005) suggests that the majority of studies published in the field of 
biomedical research are actually false, noting several tendencies characteristic of the field such, 
as bias in experimental design (i.e. selective reporting of findings or post-hoc analyses of 
unspecified hypotheses), testing of the same research question by several independent research 
teams, utilization of small sample sizes to streamline experiments, and the use of outcome 
measures that are not universally agreed upon all greatly reduce the likelihood that a published 
research finding is actually true.  Further, Button et al. (2013) conducted a meta-analysis 
suggesting that studies in the field of neuroscience achieve on average only 21% statistical power 
across the field and state that the reduced power observed in these studies also reduce the 
likelihood that a statistically significant finding actually reflects a true effect.  That is, the authors 
argue that for an underpowered study to achieve a nominally statistically significant result, the 
measured effect size must be inflated beyond the point that is truly reflected in the population, a 
phenomenon known as the winner’s curse (Button et al., 2013).  Taken together, these findings 
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suggest that therapies that have been successful in animal models may have ultimately failed in 
humans because the original research findings may have been spurious from the outset. 
 Another possible explanation for the lack of translatable therapeutic research in HD may 
be that experimenters tend to select improper animal models and use poor behavioral endpoints 
to test potential therapies.  For example, Menalled and Brunner (2014) found in a meta-analysis 
of pre-clinical HD studies that only 5% of experimenters utilized cognitive endpoints and often 
relied on measures such as motor ability, survival rate, and neuropathology to determine 
treatment efficacy instead.  It can be argued that behavior represents the final output of the brain, 
so it should follow that use of KI models as well as endpoint measures that focus on behavioral 
output such as cognition, especially those that arise during the pre-manifest stage before cell 
death occurs, will improve the translation of therapies from animals to humans. 
 Of the knock-in mouse models of HD, relatively little behavioral characterization has 
been conducted on the B6.HttQ111/+ KI mouse model of HD thus far.  HttQ111/+ mice are part of an 
allelic series of KI mice created by Vanessa Wheeler and Marcy MacDonald at Massachusetts 
General Hospital consisting of 18, 48, 78, and 90 CAG repeats, and mimic the genetics of human 
HD by including 109 CAG repeats in the endogenous murine gene (Menalled et al., 2014; 
Wheeler et al., 1999).  Although initially created on a mixed 129SvEv/CD1 genetic background 
(Wheeler et al., 1999), HttQ111/+ mice and the other KI models in this allelic series are now 
maintained on a C57BL/6J inbred background to reduce variability and allow researchers to 
investigate the influence of CAG size on desired outcome measures (Menalled et al., 2014).  The 
majority of behavioral characterization associated with this model suggests mild and late onset 
behavioral phenotypes (Menalled, 2005).  Hlter et al. (2013) conducted the most comprehensive 
behavioral characterization of HttQ111/+ mice to date, finding that heterozygous mice display 
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impairments in social discrimination learning at three months, motor learning at six months, 
olfactory discrimination between six and eight months, decreased anxiety-like phenotype and 
distance traveled in the open field at nine months, and motor deficits at ten and a half months of 
age.  Both recognition deficits and long-term memory deficits on a novel object recognition and 
object relocation task have been observed at six months of age (Brito et al., 2014), as well as 
spatial memory deficits on Morris water maze probe trials at eight months of age (Giralt et al., 
2011).  Further, working memory and reversal learning deficits are observed on a delayed 
matching to position (DMTP) and delayed non-matching to position (DNMTP) task at eight 
months of age (Yhnell, Dunnett, & Brooks, 2015).  
 This thesis will continue to characterize the behavioral phenotype associated with the 
HttQ111/+ mouse model of HD by attempting to replicate the findings obtained in previous 
experiments and probing for novel behavioral phenotypes characteristic of the pre-manifest stage 
of the disease that depend on the striatum.  HttQ111/+ mice were subjected to three assays meant to 
probe different aspects of cognitive and psychiatric function.  The two-cue Morris water maze, 
developed by Lee, Duman, and Pittinger (2008), depends on dorsolateral striatal function and 
measures procedural learning and memory ability that is impaired during the pre-manifest stage 
of HD.  The open field test provides an index of anxiety-like phenotype and spontaneous 
locomotor activity, and measures HD related psychiatric symptoms.  Lastly, the object location 
task depends on hippocampal function and probes spatial long-term memory deficits that emerge 
during the manifest stage of HD.  We hypothesize that the results obtained from a large cohort of 
nine month old HttQ111/+ mice will provide a cross-sectional snapshot of cognitive ability, thus 
making both the HttQ111/+ mouse model and subsequent behavioral assays a suitable option for 
pre-clinical trials aiming to test novel therapeutics during the pre-manifest stage of HD. 
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Methods 
Ethical Considerations 
 All procedures involving the use of experimental animals were approved by the Western 
Washington University Institutional Animal Care and Use Committee and were in accordance 
with the Guide for the Care and Use of Laboratory Animals described by the National Institutes 
of Health.  
Experimental Animals 
 Experimental animals consisted of sixty-one female C57BL/6J mice.  Of these, 32 mice 
were HttQ111/+ heterozygous mutant mice, and 29 were Htt+/+ counterparts used as controls. Mice 
were housed under reverse light/dark cycle conditions (12:00 pm – 12:00 am dark cycle) and 
were provided access to food and water ad-libitum.  All testing was conducted between 1:00 pm 
and 9:30 pm, during the active phase of the experimental animals. 
Materials and Procedure 
 Two-cue Morris water maze. 
 Procedural learning was assessed using a two-cue Morris water maze (MWM) task 
adapted from the procedure used by Lee et al. (2008).  The MWM apparatus consisted of a 
circular pool (125 cm diameter; water depth of 51.5 cm) filled with room temperature water 
made opaque with the addition of white, non-toxic latex paint.  Four positions outside the maze 
were arbitrarily designated as north (N), south (S), east (E), and west (W) to provide starting 
locations and to divide the maze into four quadrants: NW, SW, NE, & SE.   Testing consisted of 
four sub-components: shaping, one-cue training, two-cue training and probe trials.  For all phases 
of the experiment, animals were moved into the water-maze room and allowed to habituate for 
30 minutes prior to testing. 
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 Shaping and one-cue training. 
 At four and a half months of age, each experimental animal was exposed to the task for 
three consecutive days.  Day one consisted of shaping.  Each mouse was placed upon a black 
platform made of acrylic plastic (12x12 cm) located 1 cm below the surface of the water and 
marked with a neutral grey cue (5 cm diameter, 11 cm high).  During shaping, animals were 
permitted to rest upon the platform for 30 seconds before being returned to their home cage.  
Any experimental animal that left the platform before meeting the 30 second criteria was gently 
guided back to the platform a maximum of two times, after which the trial was terminated and 
the animal was returned to its home cage.  This procedure was repeated four times total for each 
mouse.  Platform location for each trial was pseudorandomized such that every mouse was 
exposed to each quadrant once, with an inter-trial interval of approximately 30 minutes.  
 Following shaping, days two and three consisted of one-cue training.  Once again the 
escape platform was marked with the neutral grey cue, and placed in the center of one quadrant 
(i.e. NW, SW, NE, or SE).  For each trial, mice were placed in the water facing toward the wall 
at a point opposite from the escape platform (i.e. if the escape platform were located in the NW 
quadrant, entry location could be either south or east).  Mice were permitted to search for the 
platform for a maximum of 120 seconds; if a mouse did not find the platform in the allotted time, 
they were gently guided toward the escape platform a maximum of two times before the trial was 
terminated and they were returned to their home cage.  Upon finding the platform, mice were 
permitted to rest for 15 seconds.  If a mouse failed to reach the 15 second criteria, they were 
gently guided back toward the platform a maximum of two times.  Mice that left the platform 
more than two times total were returned to their home cage, and the training trial was terminated.  
As with shaping, this procedure was repeated four times total for each mouse, and platform 
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location was pseudorandomized between trials such that every mouse was exposed to each 
quadrant once, with an inter-trial interval of approximately 30 minutes.  
 Two-cue training and probe trials. 
 At nine months of age, experimental animals were tested on the two-cue version of the 
MWM for seven days, consisting of four trials per day and with a 45-minute inter-trial interval 
between each trial.  During two-cue training trials, a goal cue was marked with one of two 
distinct visual cues (5 cm diameter, 11cm high; painted with either horizontal or vertical black 
and white stripes), and an escape platform made of white acrylic plastic (15 cm diameter) was 
placed in the center of a quadrant 1 cm below water level.  The remaining visual cue (i.e. the lure 
cue) was placed in a quadrant adjacent to the goal cue and did not permit the animal to escape, 
but was visually identical to the goal cue except for the pattern.  Goal cue and lure cue patterns 
were counterbalanced between mice, and held constant throughout the duration of the two-cue 
phase (i.e. for each mouse, goal cue and lure cure pattern remained the same across all trials).  In 
this way, experimental animals were forced to associate one of the visual patterns with escape 
from the maze.  To further reinforce the use of visual pattern as a means of escape, the goal cue 
was never placed in the same location twice in a row, and the relationship of the lure cue to the 
goal cue (i.e. left or right, depending on starting location) was never the same more than twice in 
a row.  In all, eight orientations of goal cue, lure cue, and starting location were possible.  Each 
animal was pseudorandomly exposed to each orientation once for every two days of training.  
For a schematic of all possible MWM orientations, see Figure 3. 
For each two-cue training trial, mice were placed into the maze at the pre-determined 
starting location facing toward the wall, and were permitted to search for the escape platform for 
a maximum of 120 seconds.  Mice who successfully reached the escape platform were permitted 
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to rest for 15 seconds before being returned to their home cage.  If an animal successfully 
navigated to the escape platform but left before reaching the 15 second criteria, the trial 
continued until the mouse returned to the escape platform for 15 continuous seconds or a 
maximum trial of 120 seconds was reached.   
 During the fourth trial of days three, five, and seven, a probe trial was administered to 
assess procedural memory.  The orientation for probe trials was determined in the same manner 
as two-cue training trials, but the escape platform was removed to make escape impossible.  
Probe trials began by placing the mouse into the maze at the pre-determined starting location 
facing toward the wall, after which mice were permitted to swim freely for 60 seconds.  After the 
60 second probe trial had elapsed, mice were removed from the water-maze and returned to their 
home cage.   
 During both two-cue training trials and probe trials, the swim pattern of each mouse was 
recorded using an overhead camera.  Swim patterns were subsequently analyzed using Noldus 
Ethovision XT 8 (Noldus, Spink, & Tegelenbosch, 2001).  For two-cue training trials, the 
primary outcome measure was the latency to reach the escape platform during each two-minute 
trial.  For probe trials, procedural memory was interpreted as a bias for swimming in the 
quadrant containing the goal cue relative to quadrant containing the lure.  To eliminate nuisance 
variables (i.e. the time spent swimming in quadrants containing neither the goal or the lure), time 
spent in the goal quadrant was calculated as a percentage of the total time spent in both the goal 
and lure quadrant, using the formula: Goal Preference = Goal Occupancy/ (Goal 
Occupancy+Lure Occupancy).  The proportion of time spent in the goal quadrant relative to the 
lure quadrant (i.e. the goal preference), and the change in goal versus lure quadrant preference 
over each day of probe trials was then compared between genotypes.  Mice were considered to 
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have intact procedural memory if they displayed a preference for the goal quadrant relative to the 
lure quadrant during probe trials.  
 Open field.  
 Immediately following two-cue MWM testing, nine month old mice were subjected to 
the open field test, which assesses anxiety levels, exploratory behavior, and spontaneous 
locomotor activity, during the habituation phase of the object location task (OLT), described 
below.  Days one and two of the OLT each consisted of habituation to a novel arena, which was 
constructed of a white acrylic plastic floor measuring 44x44 cm, with black acrylic plastic walls 
measuring 44 cm high.  On both days one and two, mice were placed in the arena in the absence 
of any objects and were permitted to explore freely for 10 minutes.  Between trials, the floor and 
walls of the arena were cleaned thoroughly using 70% EtOH.  During open field testing, activity 
was recorded using an overhead camera, and open-field behavior obtained during day one was 
analyzed using Noldus Ethovision XT 8 (Noldus, Spink, & Tegelenbosch, 2001).   
 The primary behavioral measures obtained during the open field task included total 
ambulation (i.e. total distance traveled), the amount of time spent actively exploring the arena, 
average velocity, thigmotaxis (i.e. time spent along the walls compared to the center of the 
arena), which is believed to measure of anxiety levels in mice (Simon, Dupuis, & Costentin, 
1994).  Average velocity was calculated by dividing the total distance traveled by the amount of 
time that mice spent actively exploring the arena.  Thigmotaxis levels were assessed by creating 
three concentric zones inside the open field arena: an outer zone, an intermediate zone, and an 
inner zone.  To eliminate nuisance variables (i.e. the time spent in the intermediate zone), the 
time spent along the wall of the arena was expressed as a percentage of the total time spent in 
both the inner zone and the outer zone using the formula: Wall Preference = Outer Zone 
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Occupancy/ (Outer Zone Occupancy+Inner Zone Occupancy).  Scores were compared between 
genotypes, and mice were considered less anxious if they spent more time in the center of the 
arena (Figure 4a) than against the wall (Figure 4b). 
 Object location task. 
 Following open field testing on days one and two, nine month old mice were tested on 
the object location task (OLT), which probes spatial long-term memory and is known to depend 
upon the function of hippocampus (Murai, Okuda, Tanaka, & Ohta, 2006).  On day three, mice 
were subjected to the acquisition phase of the object OLT.  Four sets of identical objects were 
used: Erlenmeyer flasks, terra cotta pots, Nalgene bottles filled with blue food coloring, or 
Nalgene bottles covered with textured coozies.  Pilot testing was conducted prior to ensure that 
no one object was more appealing to the mice than another, and all objects were counterbalanced 
between experimental animals to ensure equal representation.  Large intra-maze cues (a square, a 
triangle, an equal sign, and a plus) were taped to the walls of the arena along the north, south, 
west and east wall respectively, since research has indicated that visual depravation of spatial 
cues can obscure results (Murai et al., 2006).  Mice were placed into the apparatus such that they 
were facing two identical objects (i.e. facing north) placed in the NW and NE corners of the 
arena, and were permitted to explore for 10 minutes.  Following each trial, the apparatus and 
objects were cleaned thoroughly with 70% EtOH, and mice were placed back in their home cage 
and returned to the vivarium to rest for 24 hours.   
 On day four, mice were tested on the relocation phase of the OLT.  During relocation, 
one of the two identical objects placed in the NW or NE corner of the arena was relocated to the 
diametrically opposite corner of the arena (i.e. if the NW object was relocated, it was placed in 
the SW corner; if the NE object was relocated it was moved to the SE corner).  The object that 
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was relocated (i.e. the object to the left or the right) was counterbalanced between experimental 
animals.  During the relocation phase, mice were placed into the arena facing north and 
permitted to explore the objects for five minutes.  Following each trial, the apparatus and objects 
were cleaned using 70% EtOH and experimental animals were returned to their home cage.  The 
primary outcome measure was the number of explorations toward each object, defined as any 
event where the mouse interacted with the object or oriented its head toward the object such that 
its nose was within 2 cm proximity.  The total number of explorations to the relocated object was 
then expressed as a percentage of total explorations using the equation: Novel Preference = 
Novel Events/ (Novel Events+Familiar Events).  These data were compared between genotypes, 
and spatial long-term memory was determined to be intact if the animal displayed a preference 
for the relocated object compared to the familiar object.  To determine if there was a reduction in 
motivation to explore the objects, the total number of explorations toward both objects was also 
compared between genotypes.   
Statistical Analyses 
 All data were analyzed using the R statistical computing software (R Core Team, 2015).  
Two-cue MWM training trials and probe trials were analyzed using a repeated measures linear 
mixed effects analysis of variance (ANOVA), which allows for both fixed and random effects.  
In these analyses, genotype was treated as a fixed effect and subject specific rates of change over 
time (i.e. individual differences between mice not due to the effect of genotype) were treated as 
random effects.  Post-hoc analyses examining the effect of time, or the effect of genotype over 
time were analyzed using the Ryan-Einot-Gabriel-Welsh (REGWQ) q test in order to maintain 
the familywise error rate for each pairwise comparison at an alpha level of .05.  Total 
ambulation, active exploration time, average velocity, preference for the outer zone of the open 
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field, number of total explorations, and the proportion of explorations toward the relocated object 
were analyzed using independent samples t-tests for the open field test and OLT, respectively.  
Paired samples t-tests were used to determine relocated object preference for each genotype 
during the OLT.  
Results 
Two-cue Morris water maze 
 Two-cue Morris water maze training trials. 
 The latency to reach the escape platform during two-cue training trials was analyzed 
using a 2x7 (Genotype x Day) linear mixed effects ANOVA.  There was a main effect of day 
such that the latency to reach the escape platform varied for all mice depending on the day of 
testing, F(6,354) = 62.74, p < .001, p2 = .50.  REGWQ post-hoc comparisons suggested that 
there was a statistically significant reduction in the average latency to reach the escape platform 
for all mice between day one and days two, three, four, five, six, and seven.  In addition, the 
average latency to reach the escape platform for all mice on day two was statistically 
significantly different from the latencies to reach the escape platform on days four, five, six, and 
seven.  No other differences were statistically significant.  There was no main effect of genotype, 
F(1,59) = 0.49, p = .49, p2 = .002 and no genotype by day interaction, F(6,354) = 0.14, p = .99, 
p
2
= .003, suggesting that all mice had acquired a strategy for locating the escape platform by 
day 2 of two-cue training, and that HttQ111/+ and Htt+/+ mice acquired an escape strategy at 
similar rates (Table 1; Figure 5). 
Two-cue Morris water maze probe trials. 
 The percentage of the total time spent in the goal and lure quadrant, and the change in 
quadrant preference during each day of two-cue probe trials were compared between genotypes 
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using a 2x2x3 (Genotype x Quadrant x Day) linear mixed effects ANOVA.  Since the percentage 
of time spent in the goal and lure quadrant did not vary as a function of genotype or day (i.e. the 
total percentage of time spent in the goal and lure quadrant was always 100%) the main effects 
and interaction between these variables canceled out and were not considered in any subsequent 
analyses.  There was a main effect of quadrant such that the goal quadrant (M = .52, SD = .11) 
was preferred on average over the three days of probe trials relative to the lure quadrant (M = 
.48, SD = .11), F(1,175) = 12.74, p < .001, p2 = .04.  However, the main effect of quadrant was 
qualified by an interaction between genotype and quadrant, F(1,175) = 4.85, p = .03, p2 = .01, 
indicating that goal cue preference differed depending on genotype.  A test of simple main 
effects revealed that HttQ111/+ mice displayed a statistically significant preference for the goal 
quadrant on average over the three days of probe trials (Mgoal = .53, SD = .12; t(95) = 2.90, p < 
.01, d = 0.50), while Htt+/+ mice showed no preference for the goal quadrant overall (Mgoal = .51, 
SD = .11; t(84) = 0.61, p  =.54, d = 0.18).  There was no quadrant by day interaction, F(2,175) = 
0.35, p = .71, p2 = .002, or genotype by quadrant by day interaction, F(2,175) = 0.18, p = .83, 
p
2
 = .001.  Altogether, these results suggest that HttQ111/+ mice established a preference for the 
goal cue by day 3 that remained throughout the duration of testing while Htt+/+ mice displayed no 
preference for either the goal cue or the lure cue during any of the three days of probe trials, 
indicating improved procedural memory ability in HttQ111/+ mice (Figure 6). 
Open field 
To examine differences in exploratory behaviors and anxiety levels during the open field 
session between genotypes, a series of independent samples t-tests on outcome measures such as 
total exploratory activity, overall time spent actively exploring the arena, average velocity, and 
levels of thigmotaxis were conducted.  There was a statistically significant reduction in the 
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overall activity levels observed in HttQ111/+ mice (Mdistance = 3547.39 cm, SD = 595.06) compared 
to Htt+/+ mice (Mdistance = 4003.78 cm, SD = 781.56), t(59) = 2.58, p = .01, d = 0.66, indicating 
that  HttQ111/+ mice were hypoactive compared to Htt+/+ during the open field session (Figure 7).  
Despite traveling less overall, no differences were observed between HttQ111/+ mice (Mexploration = 
417.16 sec, SD = 46.47) and Htt+/+ mice (Mexploration = 440.51 sec, SD = 47.12) in the amount of 
time mice spent actively exploring the open field arena, t(59) = 1.95, p = .06, d = 0.50, although 
this comparison did approach statistical significance (Figure 8).  The average velocity of 
HttQ111/+ mice (Mvelocity = 8.49 cm/s, SD = 0.86) was statistically significantly reduced compared 
to Htt+/+ mice (Mvelocity = 9.02 cm/s, SD = 1.05), t(59) = 2.18, p = .03, d = 0.56 (Figure 9).  Lastly, 
a statistically significant difference was found between HttQ111/+ mice (Mwall = .90, SD = .07) and 
Htt+/+ mice (Mwall = .86, SD = .07), such that HttQ111/+ mice displayed increased levels of 
thigmotaxis and spent more time along the wall during the open field session, t(59) = -2.10), p = 
.04, d = 0.54, indicating increased anxiety levels in HttQ111/+ mice (Figure 10).  Overall, these 
results suggest that a decreased motivation to explore, subtle motor deficit, or increased anxiety 
levels may contribute to the hypoactivity observed in HttQ111/+ mice during open field 
exploration.  
Object Location Task  
 Paired samples t-tests were used to assess the preference for the relocated object relative 
to the familiar object for each genotype, and independent samples t-tests were used to assess 
relocated object preference and overall exploratory activity between genotypes.  Both HttQ111/+ 
mice (Mrelocated = .55, SD = .12; t(31) = 2.60, p = .01, d = 0.83) and Htt+/+ mice (Mrelocated = .60, 
SD = .12; t(27) = 4.41, p < .001, d = 1.67) displayed a statistically significant preference for the 
relocated object compared to the relocated object, indicating intact spatial long term memory for 
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both genotypes.  Further, there was no statistically significant difference between genotypes in 
their preference for the relocated object, t(58) = 1.41, p = .17, d = 0.36, suggesting that spatial 
long term memory was not impaired in HttQ111/+ mice relative to Htt+/+ mice overall (Figure 11).  
Interestingly, there was a statistically significant reduction in the number of total explorations 
toward both objects by HttQ111/+ mice (Mexplorations = 24.00, SD = 7.34) relative to Htt+/+ mice 
(Mexplorations = 28.50, SD = 6.50), t(58) = 2.50, p = .02, d = 0.64, suggesting that HttQ111/+ mice 
displayed a reduction in exploratory behavior similar to the one observed during open field 
exploration (Figure 12).  Altogether, these results indicate that spatial long term memory remains 
intact in HttQ111/+ mice, although a hypoactive phenotype potentially stemming from a decreased 
motivational drive to explore, a neophobic response to novelty, a subtle motor deficit, or 
increased anxiety levels leads to a reduction in the total number of explorations toward both 
objects in HttQ111/+ mice overall. 
Discussion 
 This thesis aimed to continue the behavioral characterization of the HttQ111/+ KI mouse 
model of HD, with the intent of discovering novel deficits characteristic of the pre-manifest stage 
of the disease suitable for use in pre-clinical trials.  A number of interesting phenotypes were 
uncovered in this study, including improved procedural memory relative to Htt+/+ mice during 
two-cue MWM probe trials, hypoactivity, reduced velocity, and increased anxiety levels during 
open field exploration, and a reduction in the total number of explorations toward both objects 
during the OLT. 
 During two-cue MWM training trials, HttQ111/+ and Htt+/+ mice did not differ in the rate 
which an escape strategy was acquired over the seven days of testing.  Specifically, both 
HttQ111/+ and Htt+/+ mice acquired an escape strategy by day two that held constant for the 
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remainder of two-cue MWM training trials.  Previous literature suggests that task acquisition 
ability varies in HttQ111/+ mice depending on the experimental assay being administered as well 
as the underlying cognitive ability that is being probed.  HttQ111/+ mice display normal rates of 
task acquisition but impaired memory consolidation during probe trials on a MWM task 
measuring spatial LTM ability (Giralt et al., 2011), while task acquisition and reversal learning 
are impaired in a delayed matching to position (DMTP) and delayed non-matching to position 
(DNMTP) operant task designed to measure working memory ability (Yhnell, et al., 2015).  The 
results obtained in this study ultimately indicate that acquisition of a procedural learning task 
was not impaired in HttQ111/+ mice compared to Htt+/+ counterparts during two-cue MWM 
training trials.   
Further evidence supporting this claim stems from the original experiment from which 
the two-cue MWM task was adapted.  To show that two-cue MWM performance depends on 
striatal function, Lee et al. (2008) compared the performance of healthy wild-type (WT) mice to 
mice in two experimental conditions.  In the first group, Lee et al. (2008) introduced extreme 
striatal insults in experimental mice by lesioning a large portion of the dorsolateral striatum.  In 
the second group, the authors utilized a much milder model of striatal dysfunction in KCREB 
mutant mice, which possess specific deficits in procedural learning due to localized inhibition of 
the cAMP response element-binding protein (CREB) family of transcription factors in the 
dorsolateral striatum that are critical for LTM consolidation (Pittenger et al., 2006).  While the 
mice with widespread dorsostriatal lesions were impaired during the acquisition phase of the 
two-cue MWM, KCREB mutant mice with mild striatal dysfunction acquired the task at a rate 
similar to WT mice (Lee et al., 2008).  Similar to KCREB mutant mice, phospho-CREB levels 
(i.e. the transcriptionally active form of CREB) are reduced in the cortex of HttQ111/+ mice 
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beginning at five months of age (Gines et al., 2003).  It is reasonable to assume that the 
performance of HttQ111/+ mice would more closely resemble the level of KCREB mutant mice 
than the more severely impaired mice with widespread dorsolateral striatal lesions.  Given that 
the two-cue MWM protocol was unable to detect acquisition deficits in a mild model of 
corticostriatal dysfunction in the study it was originally derived from (Lee et al., 2008; Pittinger 
et al., 2008), the lack of differences observed between genotypes during two-cue training in this 
study likely reflects the relatively subtle phenotype associated with HttQ111/+ mice. 
 Interestingly, HttQ111/+ mice outperformed Htt+/+ mice during two-cue probe trials and 
displayed a greater affinity for the goal-cue relative to the lure-cue over the three days of testing, 
which indicates that HttQ111/+ mice display improved procedural memory consolidation compared 
to Htt+/+ counterparts at nine months of age.  Although these findings do not align with the 
original hypotheses of the study, prior research suggests that the same mechanisms contributing 
to neurodegeneration in HD can also enhance some forms of learning in parallel by 
simultaneously amplifying neural plasticity in pre-symptomatic HD patients (Beste, Wascher, 
Dinse, & Saft, 2012).  Glutamatergic neurotransmission at NMDA receptors plays an important 
role in both memory consolidation and excitotoxic cell death (Beste et al., 2012).  In that regard, 
NMDA receptor activation causes an influx of Ca2+ into the postsynaptic neuron, which then acts 
as an important second messenger that can either facilitate synaptic LTP (Malenka & Nicoll, 
1999) or trigger apoptosis via caspase activation (Andre, Cepeda, and Levine, 2010) depending 
upon its concentration levels inside the cell.  Similar to the biphasic changes in dopamine levels 
observed throughout the progression of HD (i.e. increased levels during the early stages followed 
by decreased levels in the later stages) glutamate levels in the striatum are found to be increased 
during the early stages and decreased during the later stages in animal models of the disease 
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(Andre et al., 2010).  Additionally, energy metabolism deficits elicited by mHTT can cause both 
AMPA and NMDA receptors to become overly sensitive and more readily activated by 
endogenous levels of glutamate (Beal & Ferrante, 2004).  Together, this suggests that HD mice 
could potentially perform better than Htt+/+ mice during two-cue probe trials if the 
neuropathological changes occurring in the striatum of nine month old HttQ111/+ mice were to 
cause an increase in glutamatergic transmission that facilitates LTP and not widespread 
excitotoxic cell death.  In order to validate this claim, however, further studies linking 
neuropathology to cognitive function will be necessary.  
 Perhaps a more parsimonious explanation for the results obtained during two-cue probe 
trials is that the task simply did not work as anticipated.  Though HttQ111/+ mice displayed a 
statistically significant preference for the goal cue on average over the three days of two-cue 
probe trials, small effect sizes and the lack of a robust preference for the goal cue call into 
question the practical significance of this finding.  Furthermore, Htt+/+ mice never established a 
goal cue preference at any point over the course of two-cue probe trials, which likely signifies 
that the procedure was not able to measure the construct of procedural memory effectively.  Lee 
et al. (2008) contend that a degree of extinction can occur during two-cue probe trials after mice 
discover that the platform is no longer present and escape is not possible, and argue that it is 
possible for this effect to obscure the results of the experiment.  From an observational 
standpoint, mice seemed to swim arbitrarily between the two cues during two-cue MWM probe 
trials after initially discovering the escape platform was not present, possibly indicating that the 
length of probe trials was too long, which may have masked any true effects.  Alternately, the 
goal and lure cue patterns may not have been visually distinct enough, making it impossible for 
the mice to associate one of the visual patterns with escape consistently.  Robinson, Bridge, and 
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Riedel (2001) tested the visual acuity of rodents by employing a cued MWM task similar to the 
one used in this experiment, reliably marking the quadrant containing the escape platform with a 
cue card containing 1 cm stripes, while a cue card containing either 1, 2, 3, 4, 5, or 10 cm stripes 
was placed in an adjacent quadrant that did not permit escape.  Rats were unable to distinguish 
between quadrants and performed only at chance level when the lure quadrant was marked with 
anything less than a 4 cm grating on the cue card, suggesting that rodents may perceive narrow 
uniform stripes as a shade of grey rather than a distinct pattern when viewed from a distance 
(Robinson et al., 2001).  Further, Robinson et al. (2001) note that a number of other parameters 
were necessary to facilitate learning of the task, and found that rodents performed very poorly 
unless the goal and lure quadrants were separated by a barrier to punish rats that made incorrect 
responses, and the quadrants were marked with cue cards larger than 20x24.5 cm in size.  In any 
case, a number of modifications to the experimental procedure will be necessary before re-
administering the two-cue MWM again in an attempt to assay procedural memory.  
 In contrast to the somewhat ambiguous results obtained in the two-cue MWM task, the 
open field exploration session administered prior to the OLT revealed a number of clear deficits 
in HttQ111/+ mice.  The most robust phenotype observed in HttQ111/+ mice was a tendency toward 
hypoactivity during open field exploration, where HD mice were found to travel approximately 
11% less overall than their Htt+/+ counterparts during the 10 minute session.  In addition, 
HttQ111/+ mice displayed increased levels of thigmotaxis and spent more time along the wall 
during the open field session compared to Htt+/+ mice.  These findings run somewhat counter to 
the findings obtained by Hlter et al. (2013) who found HttQ111/+ mice to be hypoactive but 
display decreased levels of thigmotaxis at nine months of age.  While measurements of 
ambulation and central exploration in open field assays are often used to index anxiety related 
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behaviors in rodents (Ramos, 2008; Simon et al., 1994) it can be argued that any number of HD 
related deficits, either combined or in isolation, might contribute to the altered exploratory 
behaviors observed in HttQ111/+ mice.  Psychiatric symptoms such as apathy and depression can 
emerge during both the pre-manifest and early stages of human HD (Epping et al., 2016; Tabrizi 
et al., 2009), and may contribute to the alterations in exploratory behaviors observed in HttQ111/+ 
mice during open field exploration.   
 To discriminate between these potential causes, comparisons were made between 
HttQ111/+ and Htt+/+ mice regarding the total amount of time spent exploring the arena and the 
average velocity while exploring during the open field session.  HttQ111/+ mice appeared to spend 
less time overall exploring the during the open field session, although this failed to achieve 
statistical significance.  Further, HttQ111/+ mice displayed reduced velocity while exploring the 
open field apparatus compared to Htt+/+ mice, which also mirrors the results obtained by Hlter 
et al. (2013).  Although this finding suggests that a subtle motor phenotype that may contribute 
to the hypoactivity and reduced exploration time observed during open field testing, it is also 
possible that other ethological parameters, such as increased levels of stretched attend posturing, 
was interpreted as movement by the video tracking software and contributed to the reduced 
velocity observed in HttQ111/+ mice.  Stretched attend posturing in rodents is interpreted as a risk-
assessment behavior that usually occurs in tandem with an increase in other anxiety related 
behaviors, including a reduction in movement (Rodgers & Cole, 1993).  Prior research has 
generally failed to observe any motor related deficits in HttQ111/+ mice until very late in their 
lifespan, further suggesting that the reduced velocity observed in HttQ111/+ mice is not caused by 
a motor related impairment (Menalled et al., 2009; Menalled, 2005).  Altogether, the findings 
obtained during open field testing make it difficult to interpret whether the hypoactive phenotype 
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observed in HttQ111/+ mice stems from increased anxiety levels, increased apathy, or a subtle 
motor phenotype, and additional testing will be necessary to establish the cause of this deficit. 
 In contrast to the findings of Brito et al. (2014), no deficits were observed in HttQ111/+ 
mice when tested on the OLT.  Both HttQ111/+ and Htt+/+ mice displayed strong preferences for 
the relocated object relative to the familiar object, and no differences were observed between 
HttQ111/+ and Htt+/+ mice regarding the strength of preference for the relocated object during the 
OLT probe session. Altogether, these results indicate that spatial LTM remains intact in HttQ111/+ 
mice at nine months of age.  However, when the total number of investigations toward both 
objects were compared between genotypes, HttQ111/+ mice were found to investigate both objects 
roughly 16% less overall compared to their Htt+/+ counterparts, indicating a hypoactive 
phenotype similar to the one observed during open field testing, possibly brought on by 
decreased motivation, increased anxiety levels, or a subtle motor deficit.  Roy and Chapillon 
(2004) argue that spatial tasks relying on the tendency for rodents to explore novelty also assess 
emotional reactivity, and found that increased postnatal handling of rats, which reduces 
emotional response, increased the amount of time spent exploring a novel object in comparison 
to a second group of rats that had not been handled and remained largely inactive.  This suggests 
that a lack of exploration, which can also manifest as a lack of preference for an object, should 
not be interpreted solely as a spatial LTM impairment (Roy & Chapillion, 2004).  These findings 
also call into question the validity of the interpretations made by other researchers who have 
found spatial LTM deficits in HttQ111/+ mice on these types of tasks previously but did not report 
the number of investigations made toward each object (Brito et al., 2014; Giralt, 2008).  Further 
testing will be necessary to ensure that the spatial LTM deficits measured on these tasks do not 
39 
 
stem from increased apathy or anxiety, leading to a subsequent decrease in total explorations 
toward the objects overall. 
 Given that the statistical power of an experiment can significantly alter whether the 
results obtained reflect a true effect (Button et al. 2013), power analyses were conducted to help 
aid in the interpretation of the findings obtained in this experiment as well as provide a set of 
best practice guidelines for using the HttQ111/+ mouse model in future behavioral research. The 
results of these power analyses suggested that the assays that revealed the most robust behavioral 
phenotypes (i.e. hypoactivity during both the open field session and OLT) achieved roughly 70% 
statistical power, and a group of 75 animals (~37 per genotype) would be sufficient to obtain 
80% statistical power.  Conversely, the two phenotypes that showed smaller effect sizes (i.e. 
reduced velocity and increased thigmotaxis during open field testing) achieved only 56% 
statistical power, suggesting that a group size of 110 mice (~55 per genotype) is necessary to 
obtain 80% statistical power.  Overall, these results indicate that a large number of experimental 
animals are necessary to measure the relatively subtle behavioral phenotype associated with the 
HttQ111/+ mouse model of HD reliably, and further call into question the results obtained in 
experiments that utilized smaller sample sizes.  The majority of studies that have reported 
behavioral deficits in HttQ111/+ mice have utilized fewer than 12 animals per genotype (Brito et 
al., 2014; Giralt et al., 2011; Yhnell et al., 2015), with the exception being Hlter et al. (2013) 
and Menalled et al. (2009) who used approximately 20-24 per genotype for their experiments.  
While behavioral research can undoubtedly be time consuming and difficult to conduct, these 
results cast doubt upon whether the results obtained in the studies that used smaller sample sizes 
reflect true effects or are instead spurious relations resulting from an underpowered experimental 
design.   
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The results obtained in this study also provide a clear direction for future experiments to 
be conducted in the HttQ111/+ mouse model of HD.  Specifically, it will be important to parse out 
whether the hypoactive phenotype observed both during open field testing and during the OLT 
stems from increased anxiety, apathy, depression, or a subtle motor phenotype.  Behavioral tests 
such as the elevated plus maze and light/dark apparatus are used to measure anxiety like 
phenotype in rodents (Ramos, 2008) and could be employed to validate the increased levels of 
thigmotaxis observed in HttQ111/+ mice during open field testing.  The Porsolt swim test, a 
measure of behavioral despair used to measure depressive like symptoms in rodents (Castagné, 
Porsolt, & Moser, 2006), could similarly be used to see whether the hypoactive phenotype 
observed in HttQ111/+ mice is caused by increased depression levels.  Lastly, motivation levels in 
HttQ111/+ mice may be assayed by utilizing a progressive ratio operant task, which requires 
rodents to progressively increase the number of lever presses necessary to receive a food reward 
(Trueman, Dunnett, & Brooks, 2012).  Given the subtle phenotype associated with HttQ111/+ 
mice, tasks that utilize the operant chamber to probe different cognitive functions are especially 
appealing because they provide well defined outcome measures, greatly reduce the variability 
stemming from confounding variables (e.g. handling of the animals), and are a high throughput 
option to collect large amounts of data in a relatively short amount of time (Trueman et al., 
2012).   
 Lastly, it is important to identify a number of limitations that may have influenced the 
results obtained in this study and limited the generalizability of the findings.  First, female mice 
were used exclusively in this experiment, which did not allow any gender effects to be identified 
on any of the behavioral assays.  Previous research has identified gender effects on behavioral 
tests such as social discrimination learning in males (Hlter et al., 2013), and the accelerating 
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rotarod at very late ages in females (Menalled et al., 2009).  While no gender effects have yet 
been reported in HttQ111/+ mice during open field testing or the OLT, the possibility exists that 
gender effects exist on these tasks that were missed by omitting male mice from the experiment. 
A second potential limitation stems from the experimental animals that were used in this study.  
All experimental animals that were used in this experiment came from the control arm of a 
concurrent study assessing the efficacy of peripheral injections of antisense oligonucleotides 
(ASO) as a treatment for HD.  This means that each experimental animal was subjected to a 
weekly control ASO or saline injection beginning at two months of age, making it possible that 
the increased handling or stress that was induced from these weekly injections differentially 
affected HttQ111/+ and Htt+/+ mice and potentially confounded the results of the experiment. 
Finally, the order that the behavioral tests were administered may have affected the outcome of 
the behavioral tests.  Since the main objective of this thesis was to identify behavioral tests 
sensitive to measuring cortico-striatal dysfunction, the two-cue MWM test was administered 
first, followed by the open field test and OLT.  It is possible that exposing the experimental 
animals to a water based task such as the two-cue MWM may have elevated stress levels and 
influenced the results of the subsequent assays. 
 The results obtained in this experiment suggest a number of robust behavioral phenotypes 
in HttQ111/+ mice that more closely resemble features of the pre-manifest stage of the disease than 
traditionally used measures such as motor function and survival rate.  Specifically, HttQ111/+ mice 
display increased hypoactivity, increased anxiety, and decreased velocity compared to Htt+/+ 
mice, although further testing will be necessary to uncover the cause of these phenotypes.  
Further, a series of power analyses conducted upon the data collected in this experiment also 
provide improved guidelines regarding the number of experimental animals that are necessary to 
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achieve reliable results using the HttQ111/+ mice in future studies.  Given that pre-clinical HD 
research stands the greatest chance of successfully translating to humans if researchers select 
animal models that are genetically faithful and clinical endpoints that measure the earliest and 
subtlest pathogenic changes, the results obtained in the current study provide an important 
platform for improving the quality of pre-clinical behavioral research conducted in the HttQ111/+ 
mouse model of HD in the future. 
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Table 1 
Mean Latencies to Locate the Escape Platform during Two-cue MWM Training by Day. 
 
Htt+/+ HttQ111/+ Total 
Day M (SD) M (SD) M (SD) 
1 24.47 (27.41) 24.57 (28.56) 24.53 (27.97) 
2 10.10 (8.65) 10.93 (8.51) 10.53 (8.57)* 
3 7.15 (5.77) 8.86 (6.90) 8.05 (6.43)* 
4 7.20 (5.20) 7.74 (6.47) 7.49 (5.89)*† 
5 6.36 (4.61) 6.99 (7.01) 6.69 (5.98)* † 
6 6.14 (4.98) 5.77 (3.91) 5.95 (4.45)* † 
7 5.99 (3.89) 5.96 (4.32) 5.97 (4.11)* † 
Note: Dependent variable = Latency to reach escape platform. An asterisk (*) indicates values 
were statistically significant from day 1 at the p < .05 level. A dagger (†) indicates values were 
statistically significant from day 2 at the p < .05 level. 
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Figure 1. Schematic of the direct, indirect, hyper-direct, and dopaminergic projections 
within the basal ganglia.  Glutamatergic connections are represented in red, GABAergic 
connections in blue, and dopaminergic connections in green.  Activation of the “direct” pathway 
results in the inhibition of the GPi and SNr, followed by the disinhibition of thalamic feedback to 
the cerebral cortex.  Activation of the “indirect” pathway removes the tonic inhibition of the GPe 
from the GPi and STN, further strengthening inhibition by the GPi and SNr upon the thalamus, 
which suppresses thalamic feedback to the cerebral cortex overall.  DA = dopamine; SNpc = 
substantia nigra pars compacta; SNpr = substantia nigra pars reticulata; GPe = globus pallidus – 
external segment; GPi = globus pallidus – internal segment; STN = subthalamic nucleus.  
Adapted from Papoutsi et. al, (2014).     
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Figure 2. Schematic of the gradient of pathology observed during early manifest HD.  
Glutamatergic connections are represented in red, GABAergic connections in blue, and 
dopaminergic connections in green.  Changes in signaling due to neuropathological changes are 
represented with either dashed lines (decrease) or bolded lines (increase.)  Neurodegeneration 
along the indirect pathway increases the tonic inhibition of the GPe upon the GPi and STN, 
disinhibiting thalamic feedback to the neocortex.  Concurrently, direct pathway MSNs become 
over activated due to increased levels of extracellular glutamate, disinhibiting the thalamus even 
further.  DA = dopamine; SNpc = substantia nigra pars compacta; SNpr = substantia nigra pars 
reticulata; GPe = globus pallidus – external segment; GPi = globus pallidus – internal segment; 
STN = subthalamic nucleus.  Adapted from Papoutsi et. al, (2014). 
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Figure 3.  Schematic of the eight possible MWM orientations and entry locations.  Goal cue 
location is shaded in green, and lure cue location is shaded in red.  Entry location for each 
orientation is represented with an arrow.  Adapted from Lee, Duman, and Pittinger (2008). 
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Figure 4.  Visual representation of the concentric zones used to measure thigmotaxis in 
experimental animals.  Mice were considered less anxious if they spent more time occupying the 
inner zone (a) than the outer zone (b). 
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Figure 5. Average latency to reach the escape platform during two-cue Morris water maze 
training trials by day.  Error bars represent 95% CI.  A double asterisk (**) indicates values were 
statistically significantly different at the p < .01 level.   
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Figure 6. Percentage of  total time spent in the goal and lure quadrants during two-cue MWM 
probe trials.  Error bars represent 95% CI.  A double asterisk (**) indicates post-hoc simple 
effects were statistically significant at the p < .01 level. 
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Figure 7. Total distance traveled (cm) by Htt+/+ and HttQ111/+ mice during the OF session.  Error 
bars represent 95% CI.  A double asterisk (**) indicates values were statistically significant at 
the p = .01 level. 
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Figure 8. Total time spent actively exploring by Htt+/+ and HttQ111/+ mice during the open field 
session.  Error bars represent 95% CI. 
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Figure 9.  Average velocity (cm/s) of Htt+/+ and HttQ111/+ mice during the open field session.  
Error bars represent 95% CI.  An asterisk (*) indicates values were statistically significant at the 
p < .05 level. 
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Figure 10. Percentage of total time spent along the wall by Htt+/+ and HttQ111/+ mice during the 
open field session.  Error bars represent 95% CI.  An asterisk (*) indicates values were 
statistically significant at the p < .05 level. 
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Figure 11. Percentage of total investigations by Htt+/+ and HttQ111/+ mice to the familiar and 
relocated objects during the OLT.  Error bars represent 95% CI.  A double asterisk (**) indicates 
values were statistically significant at the p = .01 level. 
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Figure 12. Total number of investigations to the familiar and relocated objects by Htt+/+ and 
HttQ111/+ mice during the OLT.  Error bars represent 95% CI.  An asterisk (*) indicates values 
were statistically significant at the p < .05 level. 
